FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10575911000001105: Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36068901000001119 Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36069001000001112 Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Is pack of Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has active ingredient Monobasic potassium phosphate false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has active ingredient Sodium acid phosphate anhydrous false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has VMP Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has specific active ingredient Monobasic potassium phosphate true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has specific active ingredient Sodium acid phosphate anhydrous true Inferred relationship Existential restriction modifier
Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
K-Phos No.2 tablets (Beach Pharmaceuticals) 100 tablet Is a True Sodium acid phosphate 700mg / Potassium dihydrogen phosphate 305mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start